🔥Telegram İfşa

Arda's team is expanding! We've opened two new computational roles: a computational biologist and a data engineer. Bring your single cell analysis chops and help us make drugs that target cells, not pathways. ardatx.notion.site/ardatx/Job-Boa….

Today, Arda Therapeutics's bench gets deeper. Welcome Martin!

This will be a symposium to remember! The speaker lineup includes stellar scientists, energetic entrepreneurs, driven drug developers...and me, apparently the abbot of aggressive alliteration.

Thanks for a nice discussion, T Grant Belgard 🧬💻 and the The Bioinformatics CRO team!

Glad to see longevity research starting to pervade the halls of Congress. Nice work @TheA4li team!

The new Arda website is live at ardatx.com. Check it out to learn about our science, our incredible team, and more!

This is our first job opening in several months, and likely our last for a few more months!

Help save the Dog Aging Project. Despite being one of the most influential, productive and impactful NIH supported projects over the past 5 years, the National Institute on Aging has inexplicably chosen to withdraw support for the Dog Aging Project. For now, I’m won't get into

We're thrilled to announce that Scott Turner (Scott Turner) has joined us as Arda's new Chief Scientific Officer! Scott brings a wealth of experience and expertise in the development and translation of anti-fibrotic therapies from his former role as CSO at Pliant Therapeutics. Welcome!

A wonderful day here at Arda Therapeutics. $43M to continue advancing our pipeline, developing our platform, and exploring the potential of pathogenic cell depletion to treat chronic diseases! Come build with us: ardatx.com/careers.

Honored to re-up with with Becky Pferdehirt, Vineeta Agarwala, and the rest of the a16z Bio + Health team!

Arda’s founders, CEO Adam Freund and CTO Rémi Laberge, joined the Translating Aging to explore Arda's cutting-edge approach to treating chronic diseases. Adam and Remi discussed Arda’s origin and shared how the company's single-cell-based discovery platform pinpoints pathogenic

If you are a scientist, investor, or potential business partner interested in longevity biotech, this is an up-to-date overview of leading companies in the space, including Arda Therapeutics. Nice job Healthspan Capital